ClinicalTrials.gg
CompletedNCT04028128COCOFATUpdated Sep 26, 2019

High Flavonols Cocoa Intake for the Improvement of Body Fat Composition in Athletes

An interventional study of Cocoa group and Placebo group in Healthy Subjects, sponsored by Universidad Europea de Madrid. Completed at 1 site in Spain. Open to male participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-09-26.

Sponsored by Universidad Europea de Madrid · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 1 year 6 months after the study started (first participant enrolled Jan 2018, registered Jul 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Male
01

Study summary

The decrease in body fat percentage improves exercise performance, reducing race time. The intake of cocoa improves the body fat composition in obese and diabetic people by improving their cardiovascular disease risk factors. Although epidemiological studies indicate that healthy subjects who consume cocoa have lower body fat composition, there is no study indicating whether cocoa improves fat composition in athletes. The aim of the study was to determine if the intake of cocoa rich in flavonoids improves the fat composition of athletes, modifying the systemic levels of adipokines (folistatin, myostatin and leptin), resulting in an improvement of physical performance.

Read the detailed description

The objective of this project was to investigate the effects of chronic daily consumption of high in flavanols cocoa in body composition and performance of endurance athletes:

A randomized, blinded, parallel placebo controlled intervention study was carried out in endurance athletes . The number of male athletes enrolled in the study was 40, with ages between 18 and 50 years and an aerobic power consumption of oxygen greater than or equal to 55 mL / kg / min). The intervention was carried out for 10 weeks. Cocoa or placebo (maltodextrin) were supplied in sachets of a single daily dose. Cocoa provided 425 mg of flavanols/ day.

Athlete's body composition was evaluated by dual-energy X-ray absorptiometry (DEXA). Exercise performance was evaluated with a treadmill test protocol determining the maximum aerobic capacity and also by determining the time necessary to run a kilometer at maximum speed.

Adipokines (follistatin, myostatin and leptin) in plasma and serum samples were determined by ELISA.

Diet was determined by three 24h-recall questionnaries and a Food Frecuency questionnaire.

02

Conditions studied

  • Healthy Subjects

Keywords

  • Nutritional Supplement
  • High in flavanoids cocoa
  • Body Fat composition
  • Physical Exercise performance
03

In context

Lead sponsor

Universidad Europea de Madrid is the lead sponsor of 99 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Men.
  • Age between 18 and 50 years
  • Aerobic power of oxygen consumption greater than or equal to 55 mL / kg / min

Exclusion criteria

Exclusion Criteria:

  • Intake of chronical medication.
  • Intake any type of nutritional or ergogenic supplements.
  • Vegetarian or vegan diet
  • Smoke.
  • Any diagnosed disease at the time of inclusion or during the study
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Cocoa group

    The cocoa was provided in 5 g sachets. The intervention last 10 weeks. Cocoa was provided in a single daily dose of 5 g, which provided 425 mg of flavonoids

    Dietary Supplement: Cocoa group

  • Placebo comparator
    Placebo group

    Maltodextrin (5 g) was supplied as placebo in sachets identical to those provided for cocoa.

    Dietary Supplement: Placebo group

Interventions

  • Dietary supplementCocoa group

    Athletes performed a training program and consumed 5 g of cocoa (425 mg of flavonoids) mixed with semi-skimmed fat milk, daily for 10 weeks.

  • Dietary supplementPlacebo group

    The athletes performed the same training program of the cocoa group and they took for 10 weeks 5 g of maltodextrin mixed with semi-skimmed fat milk.

06

What researchers measure

Primary outcomes

  1. Change of body fat mass at 10 weeks

    Energy X-ray absorptiometry (DEXA).

    Time frame: Fat mass was analyzed at the beginning (baseline time = 0) and after 10 weeks of intervention

Secondary outcomes

  1. Change of lean mass at 10 weeks

    Energy X-ray absorptiometry (DEXA).

    Time frame: Lean mass was analyzed at the beginning (baseline time) and after 10 weeks of intervention

  2. Change in Sport performance test at 10 weeks

    Assessment of maximal aerobic capacity by treadmill test

    Time frame: Sport performance was analyzed at the beginning (baseline time) and after 10 weeks of intervention

  3. Change in Sport performance test 2 at 10 weeks

    Measurement of the time that the sportsmen spend running one kilometer at the maximum speed.

    Time frame: Sport performance was analyzed at the beginning (baseline time and after 10 weeks of intervention

  4. Change from baseline of adipokines at 10 weeks

    Myostatin and Follistatin levels were measured in plasma

    Time frame: Myostatin and Follistatin were analyzed at the beginning and at the end of the 10-week intervention.

  5. Change from baseline of leptin

    leptin levels were measured in plasma by ELISA

    Time frame: Leptin was analyzed at the beginning and at the end of the 10-week intervention.

  6. Change in Dietary habits at 10 weeks

    Food Frequency Questionnaire. Consumption data were obtained for 93 foods. These data were entered into the DietSource software 3.0 (Novartis, Barcelona, Spain) to transform food data into percentage of carbohydrates, percentage of proteins and percentage of fat in the diet.

    Time frame: Diet was analyzed at the beginning (baseline dose) and after 10 weeks of intervention.

  7. Change in Dietary habits 2 at 10 weeks

    24h recall questionnaire. This questionnaire was carried out 3 times on different days (2 weekdays and one weekend day) at the beginning (baseline) and after 10 weeks of intervention.These data were entered into the DietSource software 3.0 (Novartis, Barcelona, Spain) to transform food data into percentage of carbohydrates, percentage of proteins and percentage of fat in the diet.

    Time frame: Diet was analyzed at the beginning (baseline dose) and after 10 weeks of intervention.

07

Study locations

1 site
  • Jose Ángel García Merino
    Villaviciosa de Odón, Madrid 28670, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 26, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04028128
Lead sponsor
Universidad Europea de Madrid
Collaborators
Ministerio de Economía y Competitividad, Spain
Responsible party
Mar Larrosa (Tenure Professor, Universidad Europea de Madrid) — Principal investigator
First posted
Jul 22, 2019
Start date
Jan 1, 2018
Primary completion
Feb 20, 2019
Completion
Apr 1, 2019
Last update
Sep 26, 2019

Study contacts

María del Mar Larrosa Pérez, PhD
principal investigator · Universidad Europea de Madrid

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Cocoa bean

Start the discussion